Advertisement

Topics

Athera Biotechnologies AB Company Profile

10:10 EST 23rd November 2017 | BioPortfolio

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two biopharmaceutical product candidates aimed at treating patients with acute heart conditions and a biomarker linked to the therapeutic approach. Athera is a Karolinska Development AB (publ) portfolio company and is also a major partner in the highly ranked EU-project CVDIMMUNE, which also includes Karolinska Institute, Imperial College London, Phadia GmbH and TNO.


News Articles [93 Associated News Articles listed on BioPortfolio]

Athera Biotechnologies Initiates Phase IIa Trial On Arterial Inflammation With Its Antibody PC-mAb

Athera initiates Phase 2a trial on arterial inflammation with its antibody PC-mAb Stockholm October 11, 2017 Athera Biotechnologies AB today announced that screening has started for a Phase 2a prospec...

Athera Biotechnologies Allowed US Composition Of Matter Patents For Therapeutic Antibodies

  Life Sciences Jobs   ...

Athera Biotechnologies Completes Financing To Advance Clinic With Immunovascular Antibody

  Life Sciences Jobs   ...

Athera Biotechnologies Completes Financing To Advance Clinic With Immunovascular Antibody Aug 29, 2017

  Life Sciences Jobs   ...

Athera Biotechnologies Concludes Follow-Up Visits In Multiple Dosing Trial With Its Immunovascular Antibody

  Life Sciences Jobs   ...

Athera raises SEK57M

Athera begins Phase IIa trial of PC-mAb for arterial inflammation

Athera Biotechnologies AB Pharmaceuticals Healthcare Deals and Alliances Profile. [Report Updated: 20072017] Prices from USD $250

SummaryAthera Biotechnologies AB Athera is a biopharmaceutical company that develops targeted anti inflammatory biological candidate drugs and companion diagnostics for cardiovascular disease. The com...

Drugs and Medications [0 Results]

None

PubMed Articles [13 Associated PubMed Articles listed on BioPortfolio]

Ethical principles for the use of human cellular biotechnologies.

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Overcoming the energetic limitations of syngas fermentation.

The fermentation of synthesis gas (including carbon monoxide, carbon dioxide, and hydrogen) with anaerobic acetogens is an established biotechnological process that has recently been transferred to a ...

'You are inferior!' Revisiting the expressivist argument.

According to the expressivist argument the choice to use biotechnologies to prevent the birth of individuals with specific disabilities is an expression of disvalue for existing people with this disab...

Electricity production and microbial characterization of thermophilic microbial fuel cells.

Thermophilic microbial fuel cell (TMFC) offers many benefits, but the investigations on the diversity of exoelectrogenic bacteria are scarce. In this study, a two-chamber TMFC was constructed using et...

Clinical Trials [0 Results]

None

Companies [102 Associated Companies listed on BioPortfolio]

Athera Biotechnologies AB

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

Athera Biotechnologies & ALPCO

Athera has a unique and in-depth understanding of the immunological components in atherosclerosis, the inflammatory process leading to cardiovascular disease (CVD). The company currently has two b...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

Genemed Biotechnologies Incorporated

Genemed Biotechnologies Inc. provides high quality contract manufacturing services for a wide variety of research and diagnostic products including native or recombinant proteins and nucleotides

More Information about "Athera Biotechnologies AB" on BioPortfolio

We have published hundreds of Athera Biotechnologies AB news stories on BioPortfolio along with dozens of Athera Biotechnologies AB Clinical Trials and PubMed Articles about Athera Biotechnologies AB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athera Biotechnologies AB Companies in our database. You can also find out about relevant Athera Biotechnologies AB Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...


Corporate Database Quicklinks



Searches Linking to this Company Record